4basebio PLC (AIM:4BB)
London · Delayed Price · Currency is GBP · Price in GBX 760.00
-15.00 (-1.94%)
Oct 10, 2025, 1:36 PM GMT+1
4basebio Market Cap
4basebio has a market cap or net worth of 117.63 million as of October 10, 2025. Its market cap has decreased by -33.91% in one year.
Market Cap
117.63M
Enterprise Value
106.95M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
760.00
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 41.57M to 117.63M, an increase of 182.95%. That is a compound annual growth rate of 25.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 117.63M | -24.08% |
| Dec 31, 2024 | 154.94M | 84.96% |
| Dec 29, 2023 | 83.77M | -4.21% |
| Dec 30, 2022 | 87.45M | 15.45% |
| Dec 31, 2021 | 75.75M | 82.22% |
| Feb 17, 2021 | 41.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.66B |
| GSK plc | 65.98B |
| Haleon | 30.16B |
| Smith & Nephew | 11.23B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 4.02B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.68B |